Related Experiment Video
Updated: Jan 13, 2026
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Structural optimization and functional evaluation of cytisine for redox homeostasis regulation in lung cancer cells
Zhicui Qin1, Zilu Xin1, Xueli Zhang1
1College of Medicine, Linyi University, Linyi 276000, China.
Introduction:
Targeting redox homeostasis represents a promising strategy to selectively eliminate cancer cells through oxidative stress-mediated apoptosis. However, developing specific molecular entities capable of effectively disrupting this balance remains a key challenge.
Objectives:
This study aimed to construct a novel library of cytisine derivatives through rational drug design to discover lead compounds with potent redox-disrupting activity and validate their potential as precision therapy candidates for lung cancer.
Methods:
A focused library of 77 derivatives was designed and synthesized via rational modification of key pharmacophores in cytisine. The antitumor activity and mechanism of action of candidate compounds were evaluated using in vitro cellular models and in vivo animal models.
Results:
Among these, YU-C-ThioU-9 emerged as a lead compound with potent antitumor activity. Mechanistic investigations revealed that YU-C-ThioU-9 disrupts intracellular redox balance, leading to a marked accumulation of reactive oxygen species (ROS) and consequent oxidative damage. This redox perturbation, marked by oxidative stress accumulation, ultimately induces apoptotic cell death in lung cancer cells. Importantly, YU-C-ThioU-9 exhibited robust anticancer efficacy in both in vitro and in vivo models.
Conclusion:
These findings establish redox disruption as a clinically actionable avenue for precision oncology and position YU-C-ThioU-9 as a lead cytisine-derived candidate for lung cancer therapy.
Insights
Researchers developed cytisine derivatives to target cancer cell redox balance. One compound, YU-C-ThioU-9, effectively induced oxidative stress and apoptosis in lung cancer cells, showing promise for precision therapy.
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Redox Biology
Background:
- Targeting cellular redox homeostasis is a key strategy for cancer therapy via oxidative stress-induced apoptosis.
- Developing specific agents to disrupt redox balance in cancer cells is a significant challenge.
Purpose of the Study:
- To design and synthesize novel cytisine derivatives for potent redox disruption.
- To identify lead compounds for precision lung cancer therapy.
Main Methods:
- Synthesized a library of 77 cytisine derivatives.
- Evaluated antitumor activity and mechanisms using in vitro and in vivo models.
Main Results:
- YU-C-ThioU-9 demonstrated potent antitumor activity.
- This compound disrupts redox balance, increasing reactive oxygen species (ROS) and inducing apoptosis in lung cancer cells.
- YU-C-ThioU-9 showed significant efficacy in preclinical models.
Conclusions:
- Redox disruption is a viable therapeutic strategy in precision oncology.
- YU-C-ThioU-9 is a promising cytisine-derived candidate for lung cancer treatment.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...